🆕We are pleased to welcome our Affiliates and Associates to IPNA! IPNA membership is now open to multiprofessionals with an interest in #pedneph.
📢 Help us spread the message across your networks!
www.theipna.org
@alanepe.bsky.social
🆕We are pleased to welcome our Affiliates and Associates to IPNA! IPNA membership is now open to multiprofessionals with an interest in #pedneph.
📢 Help us spread the message across your networks!
www.theipna.org
Little kidneys amid large global inequities
CKD is a common non-communicable disease in children, & kidney dysfunction is the leading metabolic risk factor for death. Significant inequities exist in access to care worldwide. Read this Review of global disparities in pediatric CKD. Open Access
link.springer.com/article/10.1...
Procalcitonin kinetics in critically ill children: impact of continuous kidney replacement therapy modality and dose
AKI is common in critically ill children, frequently necessitating continuous kidney replacement therapy. Procalcitonin (PCT) is widely used as an infection biomarker. Read this Original Article on PCT kinetics in critically ill children. Open Access
link.springer.com/article/10.1...
Study findings suggest food assistance has a role in mitigating chronic kidney disease progression among children. #nephsky #pediatricnephrology #kidneydisease #CKD #foodinsecurity #socialdeterminantsofhealth
docwirenews.com/post/impact-...
The future of nephrology research is here! 🚀 ISGD Clinical Trial Bootcamps go global in 2026!
📍 Miami, Atlanta, Bordeaux & Mar de Plata.
🎟 Register for PNRC/RPA now: www.is-gd.org/time-to-train
#ISGD #ESPNSociety #PNRC @renalphysicians.bsky.social @alanepe.bsky.social @tobias-b-huber.bsky.social
Commentary
Disentangling disease heterogeneity in C3 glomerulopathies: a slippery road
doi.org/10.1016/j.kint.2025.09.031
Original article: doi.org/10.1016/j.kint.2025.08.035
#NephSky #MedSky #MPGN #kidneydisease @radboudumc.bsky.social
Prevalence of HIV-associated nephropathy in children: a systematic review with meta-analysis of studies published between 2004 and 2019
Despite major advances in antiretroviral therapy, HIV infection remains a significant global public health challenge. Read this Systematic Review /Meta-analysis of prevalence of HIV-associated nephropathy in children. Open Access
link.springer.com/article/10.1...
Commentary
Genomics of kidney volumes: one size does not fit all
doi.org/10.1016/j.kint.2025.12.003
Original article: doi.org/10.1016/j.kint.2025.08.038
#NephSky #MedSky #GWAS #kidneydisease
The first IPNA Teaching Course of 2026 was organised over the weekend by Dr. Aliza Mittal at AIIMS Jodhpur. We are pleased to have received such positive feedback!
📢 Applications for organising IPNA Teaching Courses are now open.
👉 www.theipna.org
Podocyte derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis
doi.org/10.1016/j.kint.2026.01.014
#NephSky #MedSky #OpenAccess #FSGS
Single relapse at ≥ 0.5 mg/kg alternate-day prednisone predicts course of childhood nephrotic syndrome
Around half of children w/steroid-sensitive nephrotic syndrome are eventually diagnosed w/frequently relapsing or steroid-dependent disease. Read this Original Article on how prednisone predicts course of childhood nephrotic syndrome.
link.springer.com/article/10.1...
Great discussion!
INFINITI shows SGLT2 inhibitors behave differently—but plausibly beneficially—in transplanted kidneys. What more trial evidence would you like to have before implementing in your practice? #NephJC
@theisn.org - IPNA Grand Rounds in #pedneph continue in 2026. Join us this Thursday!
🖥️Registration: shorturl.at/XDVVl
Pure poetry, so needed in more moments than we desire.
11.02.2026 19:47 — 👍 0 🔁 0 💬 0 📌 0EDITORIAL: Health-Related Quality of Life After Living Kidney Donation: Insights From a Contemporary Meta-Analysis
bit.ly/45Jd44p
Evaluation of ravulizumab trough levels in pediatric complement-mediated hemolytic uremic syndrome in remission
Ravulizumab drug monitoring has not been explored for mor maintenance therapy in patients w/complement-mediated (atypical) hemolytic uremic syndrome (aHUS). Read this Original Article on ravulizumab trough levels in aHUS in remission.
link.springer.com/article/10.1...
¡Hola #NephSky @rosertorra.bsky.social @ndt-era.bsky.social
@mdabdulqader83.bsky.social @alanepes.bsky.social
Síndrome de #Alport y trasplante renal :
#Dapagliflozin in CKD Patients with #Fabry Disease
#VisualAbstract by Elba Medina
https://www.kireports.org/article/S2468-0249(25)00760-0/fulltext